Times Square Capital Management, LLC Repligen Corp Transaction History

Times Square Capital Management, LLC

$6.51 Billion
Q4 2024

A detailed history of Times Square Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Times Square Capital Management, LLC holds 260,992 shares of RGEN stock, worth $33.9 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

260,992

Previous 275,627 5.31%

Holding current value

$33.9 Million

Previous $41 Million 8.41%

% of portfolio

0.58%

Previous 0.63%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	SELL	$123.41 - $160.92 $1.81 Million - $2.36 Million	-14,635 Reduced 5.31%	260,992 $37.6 Million
Q3 2024 Nov 04, 2024	BUY	$119.79 - $167.35 $4.21 Million - $5.88 Million	35,115 Added 14.6%	275,627 $41 Million
Q2 2024 Aug 08, 2024	BUY	$120.0 - $182.95 $5.57 Million - $8.5 Million	46,439 Added 23.93%	240,512 $30.3 Million
Q1 2024 May 07, 2024	SELL	$170.78 - $208.42 $2.02 Million - $2.46 Million	-11,810 Reduced 5.74%	194,073 $35.7 Million
Q4 2023 Feb 07, 2024	BUY	$114.17 - $185.35 $8.97 Million - $14.6 Million	78,591 Added 61.74%	205,883 $37 Million
Q3 2023 Nov 17, 2023	SELL	$138.78 - $176.51 $14.2 Million - $18.1 Million	-102,636 Reduced 44.64%	127,292 $20.2 Million
Q2 2023 Aug 09, 2023	BUY	$138.42 - $180.31 $7.92 Million - $10.3 Million	57,233 Added 33.14%	229,928 $32.5 Million
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $26.6 Million - $34.2 Million	172,695 New	172,695 $29.1 Million
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $38.8 Million - $55.4 Million	-803,991 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.8 - $58.97 $59.6 Million - $75 Million	-1,272,515 Reduced 61.28%	803,991 $0
Q2 2018 Aug 14, 2018	SELL	$35.26 - $47.04 $8.61 Million - $11.5 Million	-244,127 Reduced 10.52%	2,076,506 $97.7 Million
Q1 2018 May 15, 2018	SELL	$30.92 - $37.27 $5.89 Million - $7.1 Million	-190,487 Reduced 7.59%	2,320,633 $84 Million
Q4 2017 Feb 14, 2018	BUY	$32.53 - $38.92 $6.41 Million - $7.66 Million	196,900 Added 8.51%	2,511,120 $91.1 Million
Q3 2017 Nov 09, 2017	SELL	$36.98 - $46.06 $1.74 Million - $2.17 Million	-47,050 Reduced 1.99%	2,314,220 $88.7 Million
Q2 2017 Aug 10, 2017	BUY	N/A	2,361,270	2,361,270 $97.9 Million

Others Institutions Holding RGEN

# of Institutions

486

Shares Held

56.5M

Call Options Held

251K

Put Options Held

458K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $7.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.

Account

Times Square Capital Management, LLC Repligen Corp Transaction History